"10.1371_journal.pone.0091374","plos one","2014-03-12T00:00:00Z","Katrin Hinderhofer; Christine Fischer; Nicole Pfarr; Justyna Szamalek-Hoegel; Mona Lichtblau; Christian Nagel; Benjamin Egenlauf; Nicola Ehlken; Ekkehard Gr√ºnig","Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany; Centre for pulmonary hypertension of the Thoraxclinic, University Hospital of Heidelberg, Heidelberg, Germany","Conceived and designed the experiments: KH NP JSH EG. Performed the experiments: KH NP JSH ML CN BE NE EG. Analyzed the data: CF NE. Contributed reagents/materials/analysis tools: KH NP JSH EG. Wrote the paper: KH CF NP JSH ML CN BE NE EG.","CN receives lecture and/or consultancy fees from Actelion, GlaxoSmithKline, Pfizer, BayerHealthCare, Takeda/Nycomed, BerlinChemie, and Boehringer Ingelheim. BE receives lecture fees from Actelion. NE receives lecture fees from BayerHealthCare, Pfizer. EG receives lecture and/or consultancy fees from Actelion, Bayer, Gilead, GlaxoSmithKline, Lilly, Miltenyi, Novartis, Pfizer, RotexMedica, Alexion and received honoraria for clinical studies from Actelion, Bayer, GSK, Encysive, Lilly, United Therapeutics and Pfizer. He is member of the expert committees of BayerHealthCare, GlaxoSmithKline, Actelion, and Pfizer. There are no patents, products in development, or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","03","Katrin Hinderhofer","KH",9,TRUE,4,8,2,9,TRUE,FALSE,FALSE,0,NA,FALSE
